NASDAQ: GEMP Shareholder Notice: Investigation over Potential Wrongdoing at Gemphire Therapeutics Inc.
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Gemphire Therapeutics Inc.
View full press release